科伦药业股价上涨1.18% 子公司入选中国科技50强

金融界2025-08-21

科伦药业最新股价报37.76元，较前一交易日上涨1.18%。公司开盘价为37.36元，盘中最高触及38.18元，最低下探37.03元，全天成交金额达5.22亿元。科伦药业主要从事大容量注射剂、小容量注射剂、片剂、胶囊剂等药品的研发、生产和销售。公司控股子公司科伦博泰生物专注于创新生物技术药物及小分子药物的研发，其核心产品芦康沙妥珠单抗是国内首个完全获批的原创TROP2ADC药物。消息面上，科伦博泰...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2561968944?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-21 21:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561968944","market":"hk","top_or_hot":-1,"title":"科伦药业股价上涨1.18% 子公司入选中国科技50强","media":"金融界","content":"<div>\n<p>科伦药业最新股价报37.76元，较前一交易日上涨1.18%。公司开盘价为37.36元，盘中最高触及38.18元，最低下探37.03元，全天成交金额达5.22亿元。科伦药业主要从事大容量注射剂、小容量注射剂、片剂、胶囊剂等药品的研发、生产和销售。公司控股子公司科伦博泰生物专注于创新生物技术药物及小分子药物的研发，其核心产品芦康沙妥珠单抗是国内首个完全获批的原创TROP2ADC药物。消息面上，科伦博泰...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/08/21215352597263.shtml\">网页链接</a>\n\n</div>\n","source":"jinrongjie_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科伦药业股价上涨1.18% 子公司入选中国科技50强</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科伦药业股价上涨1.18% 子公司入选中国科技50强\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-21 21:53 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.jrj.com.cn/2025/08/21215352597263.shtml><strong>金融界</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>科伦药业最新股价报37.76元，较前一交易日上涨1.18%。公司开盘价为37.36元，盘中最高触及38.18元，最低下探37.03元，全天成交金额达5.22亿元。科伦药业主要从事大容量注射剂、小容量注射剂、片剂、胶囊剂等药品的研发、生产和销售。公司控股子公司科伦博泰生物专注于创新生物技术药物及小分子药物的研发，其核心产品芦康沙妥珠单抗是国内首个完全获批的原创TROP2ADC药物。消息面上，科伦博泰...</p>\n\n<a href=\"https://finance.jrj.com.cn/2025/08/21215352597263.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1934453819.USD","symbol_name":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","start_time":0,"source_url":"https://finance.jrj.com.cn/2025/08/21215352597263.shtml","article_id":"2561968944","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561968944","pubTimestamp":1755784424,"columns":[],"sourceInfo":{"source_id":"jinrongjie_stock","name":"金融界"},"weMediaInfo":null,"summary":"科伦药业最新股价报37.76元，较前一交易日上涨1.18%。公司控股子公司科伦博泰生物专注于创新生物技术药物及小分子药物的研发，其核心产品芦康沙妥珠单抗是国内首个完全获批的原创TROP2ADC药物。消息面上，科伦博泰生物入选2025年《财富》中国科技50强榜单，成为创新药赛道代表企业。该公司正推动中国ADC药物跻身全球第一梯队。资金流向方面，科伦药业当日主力资金净流入2935.72万元，但近五日主力资金整体呈现净流出状态，累计净流出1.54亿元。","collect":0,"end_time":0,"defaultTopTitle":"jrj.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159807":"科技50","LU1934453819.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"A\" (USD) ACC","LU1064130708.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"I\" (USD) ACC","LU1064131003.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"A\" (USD) ACC","BK0239":"医药制造","LU1979443071.USD":"AB CHINA A SHARES EQUITY PORTFOLIO \"AD\" (USDHDG) INC","002422":"科伦药业","LU2148510915.USD":"FULLERTON LUX FUNDS - CHINA A EQUITIES \"R\" (USD) ACC","BK0060":"抗癌"},"translate_title":"Kelun Pharmaceutical's stock price rose 1.18%, its subsidiary was selected into China's top 50 technology companies","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159807":1,"002422":1},"content_text":"科伦药业最新股价报37.76元，较前一交易日上涨1.18%。公司开盘价为37.36元，盘中最高触及38.18元，最低下探37.03元，全天成交金额达5.22亿元。科伦药业主要从事大容量注射剂、小容量注射剂、片剂、胶囊剂等药品的研发、生产和销售。公司控股子公司科伦博泰生物专注于创新生物技术药物及小分子药物的研发，其核心产品芦康沙妥珠单抗是国内首个完全获批的原创TROP2ADC药物。消息面上，科伦博泰生物入选2025年《财富》中国科技50强榜单，成为创新药赛道代表企业。该公司正推动中国ADC药物跻身全球第一梯队。资金流向方面，科伦药业当日主力资金净流入2935.72万元，但近五日主力资金整体呈现净流出状态，累计净流出1.54亿元。风险提示：股市有风险，投资需谨慎。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2561968944","isCrawlerRequest":true}